AAV6 Vector Production and Purification for Muscle Gene Therapy

Area of Science:

• Molecular Biology
• Virology
• Gene Therapy

Background:

• Adeno-associated virus (AAV) vectors are widely used for gene transfer in vitro and in vivo.
• AAV vectors are increasingly employed in clinical gene therapy for various human diseases.
• Current AAV vector production methods involve co-transfection of transfer and helper plasmids, with yields sensitive to procedural variations.

Purpose of the Study:

• To describe optimized protocols for generating adeno-associated virus serotype 6 (AAV6) vectors.
• To improve the efficiency of AAV vector production for gene transfer applications.
• To highlight the utility of AAV6 vectors for gene delivery to muscle tissues.

Main Methods:

• Co-transfection of plasmid vectors encoding the transgene of interest and helper genes.
• Detailed description of protocols for generating AAV6 vectors.
• Focus on optimizing steps to maximize vector yield.

Main Results:

• Established protocols for reproducible generation of AAV6 vectors.
• Demonstrated significant improvements in AAV vector yield through optimized procedures.
• Confirmed the efficacy of AAV6 vectors for gene transfer into muscle tissues.

Conclusions:

• Optimized protocols provide a reliable method for producing high-titer AAV6 vectors.
• These protocols are valuable for advancing gene therapy research and applications, especially for muscle-related disorders.
• Efficient AAV vector production is critical for the successful clinical translation of gene therapies.